These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1352827

  • 1. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [Abstract] [Full Text] [Related]

  • 2. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 3. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 4. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun 05; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [Abstract] [Full Text] [Related]

  • 5. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Jun 05; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 05; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 7. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Beschi M, Castellano M, Muiesan G.
    J Hum Hypertens; 1992 Feb 05; 6(1):9-15. PubMed ID: 1349920
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep 05; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

  • 9. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb 05; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1990 Oct 05; 12(8):563-73. PubMed ID: 2151197
    [Abstract] [Full Text] [Related]

  • 11. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
    Daae LN, Kierulf P, Brusletto B, Westheim A, Holme I, Syvertsen JO.
    Tidsskr Nor Laegeforen; 1991 Apr 10; 111(9):1102-5. PubMed ID: 1827216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A, Daae LN, Kierulf P, Brusletto B, Holme I, Syvertsen JO.
    J Hypertens Suppl; 1990 Sep 10; 8(5):S41-6. PubMed ID: 1981076
    [Abstract] [Full Text] [Related]

  • 15. Combined effect of a low fat diet and doxazosin on blood pressure control and blood lipids. Hunter Hypertension Research Group.
    J Hum Hypertens; 1994 Dec 10; 8(12):907-10. PubMed ID: 7884789
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
    Neusy AJ, Valeri A.
    J Hum Hypertens; 1990 Aug 10; 4(4):453-7. PubMed ID: 2258893
    [Abstract] [Full Text] [Related]

  • 17. Doxazosin, a new alpha-1-antagonist drug, controls hypertension without causing airways obstruction in asthma and COPD.
    Biernacki W, Flenley DC.
    J Hum Hypertens; 1989 Dec 10; 3(6):419-25. PubMed ID: 2575174
    [Abstract] [Full Text] [Related]

  • 18. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct 10; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 19. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T, Gomi T, Shibuya Y, Shinozaki S, Suzuki Y, Matsuda N.
    Hypertens Res; 2007 Nov 10; 30(11):1097-105. PubMed ID: 18250559
    [Abstract] [Full Text] [Related]

  • 20. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Nov 10; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.